NHS puberty blocker trial should not go ahead
The NHS has this week announced its £10.7 million clinical trial into care for gender-distressed children, following the recommendations of the Cass Review last year. Including the prescription of puberty-blocking drugs — currently banned in the UK — the trial has been christened Pathways. As if there are multiple ways of becoming an adult in [...]Read More...
Continue reading this article about NHS puberty blocker trial should not go ahead
by Victoria Smith
NHS Forums - For daily discussion by NHS Staff.

The NHS has this week announced its £10.7 million clinical trial into care for gender-distressed children, following the recommendations of the Cass Review last year. Including the prescription of puberty-blocking drugs — currently banned in the UK — the trial has been christened Pathways. As if there are multiple ways of becoming an adult in [...]Read More...
Continue reading this article about NHS puberty blocker trial should not go ahead
by Victoria Smith
NHS Forums - For daily discussion by NHS Staff.